Wheelchair Market Size Worth $4.2 Billion By 2026

The global wheelchair market size is expected to reach USD 4.2 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.6%. Growing disabled population along with rising geriatric population is among factors driving market growth. In addition, improvements in healthcare infrastructure are fueling the demand for wheelchairs.

Adoption and awareness of advanced wheelchairs products are also propelling growth. Growing integration of automation in healthcare devices, especially mobility devices, such as wheelchairs, is anticipated to boost growth. For instance, wheelchairs are integrated with non-linear processing circuits, guide sensors, pulse steering drive, and several controls for making the ride easy and smooth for patients.

Rising prevalence of lifestyle diseases, osteoporosis, and other autoimmune disorders that lead to the need for wheelchairs and growing baby boomers are also some factors driving the market. Presence of geriatric population is one of the key factors responsible for the largest share held by U.S. in North America.

Hospital segment held the maximum share in 2018. This can be attributed to rising high-end mobility equipment such as powered wheelchairs and manual wheelchairs, which are preferred by patients in different healthcare settings as these wheelchairs offer required mobility during hospital stays.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wheelchair-market

Further key findings from the study suggest:

Manual wheelchairs held the largest share in 2018 owing to their increasing use in hospitals
Features of electric wheelchairs such as superior quality braking system, especially to stop accidental rolling, self-reliance, and comfortability are anticipated to boost growth
Increase in medical emergencies is one of the key factors driving wheelchair market growth
Rising number of rheumatoid arthritis and osteoporosis procedures is expected to boost demand for rehabilitation wheelchairs
Adults segment held the largest share in 2018 due to presence of a high global geriatric population and rise in the prevalence of conditions requiring different types of mobility devices
North America dominated the market due to increased adoption of advanced technology in wheelchairs and rise in disabled population
Some of the players operating in the market are Carex Health Brands, Inc.; Drive Medical Design & Manufacturing; Graham-Field Health Products, Inc.; Invacare; Medline; Sunrise Medical LLC; Karman Healthcare; Quantum Rehab; Numotion; and Pride Mobility Products Corp.

Infection Surveillance Solutions Market Size Worth $1.0 Billion By 2026

The global infection surveillance solutions market size is poised to reach USD 1.0 billion by 2026, according to a new report by Grand View Research, Inc., progressing at a CAGR of 14.3% during the forecast period. Improving healthcare settings worldwide coupled with advancements in healthcare IT infrastructure is projected to play a pivotal role in the growth of the market. Rising prevalence of healthcare-associated infections (HAIs) has been one of the critical factors driving the market.

According to HAI Prevalence Survey conducted by the Center for Disease Control and Prevention (CDC), in 2014, around 722,000 cases of HAIs were detected in the U.S hospitals alone. Moreover, according to the California Department of Public Health (CDPH) in 2016, 18,924 HAIs cases were reported in 400 acute care hospitals. In addition, as per facts published by the European Commission (EC), around 25,000 people die in the European Union (EU) from antibiotic-resistant bacteria. The figure is expected to increase to 10 million deaths per year if the current infection trend continues by 2050.

Rising collaboration and government initiatives are also stimulating the growth of the market. For instance, in January 2018, the Indian Council of Medical Research (ICMR) and Pfizer, Inc. signed a partnership agreement to introduce anti-microbial resistance stewardship programs. The objective was to scale up the AMR surveillance network in India.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/infection-surveillance-solutions-market

Further key findings from the report suggest:

Surgical site infections emerged as the most promising segment during the forecast period owing to the increasing number of surgeries being performed worldwide
On the basis of the product and services segment, the on-premise software segment commanded the largest share in the market owing to its increased usage
North America dominated the market in 2017. Government programs and rising awareness about infection surveillance are facilitating the dominance of this region during the forecast period
Asia Pacific is estimated to witness swift growth during the forecast period due to increasing establishment of hospital chains and huge patient population
Few of the key market players are Wolters Kluwer N.V; Gojo Industries; Becton; Dickinson and Company; RL Solutions; Baxter International Inc.; Premier Inc.; and Truven Health Analytics (An IBM Company).

Traditional Wound Management Market Worth $7.18 Billion By 2026

The global traditional wound management market size is expected to reach USD 7.18 billion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 3.6% during the forecast period. Growing incidence of chronic diseases, increasing number of accidents, and rising number of ambulatory surgical centers are some of the key factors driving the market.

Global increase in incidence of chronic diseases such as diabetes, cancer, and other autoimmune diseases is one of the key factors driving market growth. Factors such as, adoption of unhealthy & sedentary lifestyles, alcohol consumption, and smoking are majorly contributing toward rise in prevalence of non-communicable diseases. Cancer has been a global healthcare burden as it is one of the leading causes of death. Most surgical wounds after cancer surgery are relatively large in size and deep, producing exudate, which requires routine management. The wound care products such as bandage, medical tapes, and gauze help manage large wounds, significantly reducing the risk of further infection. According to the WHO, in 2018, one in five men and one in six women, globally, develop cancer during their lifetime. Moreover, as per reports published by WHO, 18.1 million new cancer cases have been reported in 2018, globally. In addition, as per the WHO, over 70.0% of cancer-related deaths typically occur in middle- and low-income countries. Furthermore, rising prevalence of chronic conditions and growing number of surgeries being performed have also increased globally. Therefore, such factors are anticipated to positively impact growth over the forecast period.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/traditional-wound-management-market

Further key findings from the study suggest:

In terms of revenue, acute wounds segment held the largest share in 2018 owing to rising cases of accidents and trauma globally.
Gauze segment held the largest share in 2018 owing to its wide range of applicability in various types of wounds and availability of numerous products.
Hospital segment held the largest share in 2018 due to rising cases of burns and surgeries.
Asia Pacific is expected to witness the fastest growth over the forecast period owing to rising number diabetic patients in this region.
Prominent players operating in traditional wound management market are Smith & Nephew PLC, Mölnlycke Health Care, Paul Hartman AG, and Cardinal Health.

Advanced Bipolar Direct Energy Devices Market Worth $3.3 Billion By 2026

The global advanced bipolar direct energy devices market size is anticipated to reach USD 3.3 billion by 2026 registering a CAGR of 14.2%, according to a new report by Grand View Research, Inc. Increasing adoption of bipolar electrosurgical systems over conventional devices and high demand for laparoscopic surgeries are anticipated to boost the market growth.

These systems are mostly used to coagulate, cutting, fulguration, and desiccate soft tissues through generating heat by an electric current. The product demand has been increasing owing to its benefits in surgical procedures, such as lower risk of hemorrhaging than conventional devices that focus on scalpels. In addition, conventional equipment are costlier, which is also driving the demand for advanced bipolar direct energy systems for improved safety in desiccating soft tissues.

Technological advancements in the field are further expected to augment the market growth. For instance, XCELLANCE Medical Technologies launched a new 6-sense technology designed for cutting tissues at lower voltages by sensing voltage and power. This technology minimizes the patient recovery time and is a versatile tool for hemostatic dissection in performing surgical procedure.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/advanced-bipolar-direct-energy-devices-market

Further key findings from the report suggest:

Electrosurgical generator systems led the global market in 2018. The segment is projected to expand further at the fastest CAGR from 2019 to 2026
Hospital was the dominant end use segment in 2018 owing to increased number of laparoscopic surgical procedures for tissue coagulation performed in these healthcare settings
North America led the global advanced bipolar direct energy devices market in 2018. However, Asia Pacific is estimated to be the fastest-growing regional market over the forecast period
Some of the key companies in this market are Bovie Medical Corp., Medtronic PLC, B. Braun Melsungen AG, XCELLANCE Medical Technologies Pvt. Ltd., Olympus Corp., and Karl Storz
These companies focus on technological advancements to gain competitive advantage. Medtronic launched Aquamantys bipolar sealers designed by transcollation technology, which combines Radiofrequency (RF) energy and saline to provide hemostatic sealing of soft tissues

Wound Care Market Size Worth $25.1 Billion By 2026

The global wound care market size is expected to reach USD 25.1 billion by 2026, according to a new report by Grand View Research, Inc., registering a 3.9% CAGR during the forecast period. Increase in prevalence of chronic diseases globally, rising number of ambulatory surgical centers (ASCs), and growing geriatric population are key factors driving the global market.

ASCs offer a variety of services such as surgical assistance, diagnostics, and preventive procedures. Surgeries for pain management, urology, orthopedics, restorative, and gastro intestinal (GI) conditions are also performed in ambulatory surgery centers. Earlier, ASCs were only capable of performing GI-related minor surgeries; however, with increase in number of minimally invasive surgical procedures, services offered by ambulatory surgical centers have expanded and grown exponentially.

According to the U.S. Department of Health and Human Services (HHS) data records of 2014, there were 17.2 million hospital visits. These included invasive, therapeutic surgeries, and ambulatory surgeries. Around 9.94 million (57.8%) of these surgeries occurred in hospital-owned ambulatory surgery settings and the remaining 7.26 million surgeries (42.2%) were conducted in hospitals. ASCs are increasing in number and thus offer cost-effective services. In addition, favorable reimbursement coverages are being provided with regard to services provided by ASCs. The chances of contracting post-surgical, hospital-related infections are also reduced. ASCs provide specific instructions to patients regarding post-surgical homecare. Thus, with an increase in the number of ASCs and number of surgical procedures, demand for wound care is expected to increase.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/wound-care-market

Further key findings from the report suggest:

In terms of revenue, the advanced dressing segment held the largest share in 2018 owing to increasing cases of chronic diseases and rising adoption of advanced wound care products across the globe
The home healthcare segment is expected to witness the fastest growth over the forecast period due to increasing geriatric population and rising adoption of negative pressure wound therapy
On the basis of application, the acute segment held the largest wound care market share in 2018 owing to rising number of surgeries and burn cases across the globe
Asia Pacific is expected to witness the fastest growth over the forecast period owing to increasing number of surgeries and rising cases of burns in this region
Prominent key players present in the wound care market include Smith and Nephew; Molnlycke Health Care AB; and Baxter International Inc.

Elastography Imaging Market Worth $3.5 Billion By 2026

The global elastography imaging market size is expected to reach USD 3.5 billion by the end of 2026, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR over the forecast period. Increasing incidence of breast cancer and chronic liver disorders is expected to significantly drive the market. Additionally, increasing demand for minimally-invasive procedures and ongoing studies to assess the potential applications of elastography are factors expected to contribute toward rapid growth.

Currently elastography has wide applications in assessing breasts, thyroid, prostate, and liver. Increasing number of ongoing studies are expected to increase its applications in diagnosis of various conditions such neurodegenerative disorders and chronic kidney diseases. It has shown promising results for its use in assessment of kidney health during and after transplantation.

North America dominated the market in 2018 and is expected to continue its dominance during the forecast period. The elastography imaging market growth observed in the region is due to the presence of a large number of global players, along with high adoption rate for advanced imaging techniques.

Growing strategic alliances among players for development and distribution of products is expected to propel the market during the forecast period. Moreover, development of new surgical centers in different locations will increase the adoption of advanced imaging systems.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/elastography-imaging-market

Further key findings from the report suggest:

In 2018, non-cold chain logistics held the largest market share in terms of revenue owing to the sales of a large number of drugs that do not require any temperature control
Cold chain logistics segment is expected to register the faster CAGR over the forecast period owing to the demand for biologics, such as cellular therapies, vaccines, and test kits
Warehousing and storage held the largest market share among the types of services in 2018
Asia pacific expected to emerge with the fastest CAGR over the forecast period owing to adoption of medicines from aging population and shift of drug sales from brand manufacturers to generic
Key players operating in the biopharmaceutical third party logistics market include DHL International GmbH., SF Express, United Parcel Service of America, Inc, AmerisourceBergen Corporation, DB Schenker, Kuehne and Nagel, Kerry logistics network limited and AgilityBy modality, the ultrasound segment is predicted to register significant growth during the forecast period owing to advantages such as low price, accessibility, and high degree of measurement for tissue deformation
On the basis of end use, the hospital segment is anticipated to hold the largest share in the market during the forecast period due to rising number of ultrasound and MRI-based elastography procedures and growing trends of hospital-based imaging facilities
By way of application, the radiology domain is predicted to hold a large share in the market over the forecast period owing to increase in demand in image-guided radiotherapy and radiology ultrasound
Asia Pacific is anticipated to witness lucrative growth during the forecast period due to improving healthcare facilities and rising geriatric population who are prone to developing targeted disorders
Major players in the elastography imaging industry are focusing on growth strategies such as partnerships, collaborations, mergers, and acquisitions. Some of the leading players are Esaote SpA; Canon Medical Systems Corporation; Koninklijke Philips N.V.; Hitachi, Ltd.; GE Healthcare; Mindray Bio-Medical Electronics Co., Ltd.; Siemens Healthineers; Toshiba America Medical Systems, Inc.; and Samsung Medison Co., Ltd.

Ophthalmic Knife Market Size Worth $2.4 Billion By 2026

The global ophthalmic knives market size is expected to reach USD 2.4 Billion by 2026, as per a new report by Grand View Research Inc. It is projected to register a CAGR of 4.9% during the forecast period. Introduction of advanced knives and rising incidence of age related ophthalmic diseases are some of the major factors driving the growth.

Increasing overall life expectancy and rising geriatric population is expected to cause steep increase in age related ophthalmic disorders. Along with these, incidence of lifestyle associated ophthalmic devices including myopia and hypermetropia are expected showcase significant growth during the forecast period. Most of these ophthalmic conditions cannot be treated by drugs. Increasing number of ophthalmic surgeries are expected to boost the market during forecast period.

High competition and introduction of local players are the factors encouraging market players to introduce advanced knives at affordable prices. Major players are focusing on developing innovative manufacturing techniques along with advanced raw materials to reduce the device price.

Incorporation of new reimbursement policies in developed countries along with growing efforts of non-profit organizations to increase awareness about ophthalmic conditions and to provide affordable/free ophthalmic procedures in rural regions are the factors expected to boost the number of ophthalmic surgeries.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ophthalmic-knives-market

Further key findings from the report suggest:

North America captured the largest ophthalmic knife industry share in 2018 owing to favorable reimbursement policies, presence of major market players, and rise in geriatric population
Straight knives segment is anticipated to expand at a CAGR of 4.10% during the forecast period owing to fine design, durability, and sharpness of the knives
Slit knives segment is also expected to register lucrative CAGR in near future owing to extensive use for entry in anterior chamber/phaco stab incision (single bevel) in eye-related surgeries
Single-use/disposable knives segment is expected to witness significant growth over the forecast period due to features such as safety and affordability
The key players profiled in the ophthalmic knife market comprise Alcon, Inc.; Hoya Corporation; Essilor; Topcon Corporation; Hai Laboratories, Inc.; Bausch and Lomb Incorporated; MANI Inc.; Seiko Optical Products Co., Ltd.; Nidek Co., Ltd.; Ziemer Group; Alltion; and DGH Technology

Surgical Blades Market Worth $181.20 Million By 2026

The global surgical blade market size is anticipated to reach USD 181.2 million by 2026, as per a new report by Grand View Research, Inc., exhibiting a CAGR of 3.6% over the forecast period. Increase in surgeries due to increase in number of accidents, coupled with a growing geriatric population prone to various disorders, is currently driving the market. Moreover, increase in number of surgeons at a global scale is also propelling the demand for surgical blades.

Several key players are investing in R&D to launch new and innovative products. Increase in individual disposable income & standard of living, and growth in awareness regarding modern surgical procedures are other factors increasing the number of medical procedures. Increase in trauma cases and other disorders, such as cancer, which require surgery, is further augmenting demand for surgical blades. Furthermore, availability of these blades in various shapes and sizes for surgical intervention in multiple illnesses is driving the overall market.

With a wide range of procedures in healthcare, more patients are willing to undergo new treatments due to improving affordability and feasibility. Stainless steel blades are increasingly preferred due to features such as cleaner incisions, superior cutting, and numbering of scalpel handles. Being low-risk medical tools, these products do not need strict regulatory processes, which encourages and eases product launches.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/surgical-blades-market

Further key findings from the report suggest:

Surgical blades come in a variety of forms, enabling surgeons and medical staff to choose the right blade for a medical procedure
By product, stainless steel blades are expected to lead market over the forecast period, due to better anti-corrosion properties. They are more suitable for procedures involving large volumes of saline solution and multiple incisions
By material, sterile blades are expected to dominate the market since they can provide a sharp cutting edge for high efficiency, enabling cleaner incisions and superior cutting
By end use, hospitals segment accounted for a share of over 40.0% and is expected to grow at a CAGR of 3.7% over the forecast period
Some key players of surgical blades market are Swann-Morton Limited; PL Medical Co.; Hill-Rom, LLC; Beaver-Visitec International; VOGT Medical; Hu-Friedy Mfg. Co., LLC; B. Braun Melsungen AG; and Surgical Specialties Corporation.

Healthcare Reimbursement Market Size Worth $20.46 Trillion By 2026

The global healthcare reimbursement market size is expected to reach USD 20.45 trillion by 2026, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 19.0% during the forecast period. Supportive government initiatives along with rising cost of prescription medicines are likely to work in favor of the market.

Hospital, Human Heart, Medical Exam, Pharmacy, Currency

The U.S. Affordable Care Act focuses on controlling and minimizing costs of healthcare. The law supports innovative methods to deliver medical care to reduce healthcare costs and makes affordable health insurance available to more people. Since the Obamacare came into effect in 2014, the number of uninsured children under the age of 18 in the U.S. reduced to 5.0% in 2015 as compared to 9% in 2008.

In addition, the Centre for Medicare & Medicaid Services is working towards delivery of reliable high-quality care, endorsement of efficient results in healthcare system, and making health insurance affordable for millions of Americans who are seeking and getting coverage. The Medicaid spending in the U.S. grew by 3.9% in 2016 or 17.0% of the total National Health Expenditure. And Medicare spending grew by 3.6% in 2016 or 20.0% of the total National Health Expenditure.

The underpaid segment is anticipated to dominate the market through 2026 owing to growing cases of frauds against government healthcare programs and increasing use of healthcare services that are not medically required. There have been several cases where businesses and individuals have defrauded federal and state government healthcare programs by submitting false claims for healthcare services, treatment, pharmaceutical, and medical devices that were never rendered.

Also, the rivalry among healthcare providers and rising pressure from commercial and public payers to reduce costs as well as to improve care are shifting their focus towards value-based care models from volume-based healthcare models.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-reimbursement-market

Further Key Findings From the Study Suggest:

Underpaid emerged as the largest segment in 2017 owing to increasing number of insurance plans that do not cover full reimbursement
On the basis of payers, private players accounted for the leading share in the market in 2017 owing to presence of a large number of private players
North America dominated the market in 2017. A raft of insurance players and strong reimbursement framework are facilitating the dominance of the region
The market in Asia Pacific is projected to witness rapid growth during the forecast period owing to rising penetration of insurance services in rural and urban areas
Some of the market players are UnitedHealth Group, Allianz, Aviva, Aetna, Nippon Life Insurance, CVS Health, WellCare Health Plans, BNP Paribas, The Blue Cross Blue Shield Association, and AgileHealthInsurance.

Myasthenia Gravis Treatment Market Size Worth $2.06 Billion By 2026

The global myasthenia gravis treatment market size is expected to reach USD 2.06 billion by 2026 at a CAGR of 7.5% through the forecast period, according to a new report by Grand View Research. Increasing awareness of rare diseases, emergence of biologics, and growing adoption of immunotherapies & immunosuppressants are driving the myasthenia gravis (MG) treatment market.

Myasthenia gravis (MG) is a rare autoimmune disorder caused by an antibody mediated neuromuscular transmission obstruction that results in skeletal muscle weakness. Some of the disorders associated with the disease include drooping eyelids, double vision, trouble walking, and trouble talking. Patients with MG present with painless muscle weakness that worsens with repeated use and improves with rest.

According to the National Organization for Rare Disorders (NORD), in the U.S. around 14-40 per 100,000 individuals suffer from myasthenia gravis. Reports suggest that the frequency of the disorder is on the rise over the last several decades. This can be attributed to the better identification of patients and the increasing prevalence of autoimmune disorders among general public across the world. Myasthenia gravis occurs more frequently in females than in males, and although symptoms may appear at any age, its onset usually peaks in men in their 50s or 60s and in women during their 20s or 30s.

Medication held the largest market share in the treatment segment and is expected to maintain its market leading position through the forecast period. This is because medications can largely manage the symptoms and dramatically inhibit the immune system. Medications include immunotherapies such as Soliris (eculizumab), corticosteroids, and immunosuppressive drugs such as Prograf (tacrolimus) and Neoral/Sandimmune (cyclosporine). However, high cost of treatment and lack of awareness in the developing & underdeveloped countries are expected to inhibit the market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/myasthenia-gravis-mg-treatment-market

Further Key Findings From the Study Suggest:

Medications are expected to obtain the largest market share in the treatment segment. This can be attributed to the high adoption of immunotherapies and the recent approval of promising drugs.
Currently, no cure is available for myasthenia gravis, however patients can be treated with medications and surgery for the management of the symptoms.
North America is likely to dominate the MG treatment market due high healthcare expenditure and favorable reimbursement scenario
The Asia Pacific region is expected to grow at the highest CAGR over the forecast period due to improving healthcare infrastructure and increasing disposable income in the region.
Some of the major companies operating in the market include Alexion Pharmaceutical Inc., Grifols SA, Avadel Pharmaceuticals plc. Novartis AG, Pfizer, Inc., AbbVie Inc., F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Bausch Health Companies Inc., and Shire plc.